Approved for Maintenance treatment of asthma in patients aged 18 years and older, Maintenance treatment of COPD. Combines fluticasone furoate (inhaled corticosteroid) and vilanterol (long-acting beta-2 agonist). Once-daily dosing provides 24-hour anti-inflammatory and bronchodilator effects. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels,…
Loading full data from Know Your Drugs Institute…